Source: MarketScreener

Acacia Pharma: Publication of Annual Report and Financial Statements for the Year ended 31 December 2021

(marketscreener.com) This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation No 596/2014. Cambridge, UK and Indianapolis, US - 29 April 2022, 23:00 CEST: Acacia Pharma Group plc , a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of...https://www.marketscreener.com/quote/stock/ACACIA-PHARMA-GROUP-PLC-41692449/news/Publication-of-Annual-Report-and-Financial-Statements-for-the-Year-ended-31-December-2021-40223628/?utm_medium=RSS&utm_content=20220429

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Michael Bolinder's photo - CEO of Acacia Pharma

CEO

Michael Bolinder

CEO Approval Rating

90/100

Read more